The blog of the Presidential Commission for the Study of Bioethical Issues

Live from San Francisco

Welcome to the blog for the Presidential Commission for the Study of Bioethical Issue’s public meeting in San Francisco, which opens Thursday and ends on Friday, Feb. 2-3.

The meeting will focus on two issues: whole genome sequencing and neuroethics.

For a year, the Commission has been following issues surrounding the emergence of the whole genome sequencing as a part of clinical care and genetic research. Media reports say that the cost of whole genome sequencing will be reduced to around $1000 this year, which could lead to a significant increase in the use of the tests.

But many ethical issues remain around the testing, including data protection, privacy, consent, and counseling, and the potential use and abuse of data for nonmedical reasons. The Commission is expected to issue a report on the issue sometime in the fall of this year.

On neuroethics, the Commission will likely focus on advances in neuroimaging and the implications for moral philosophy and for moral and legal responsibility.

The meeting is scheduled to open at 9 a.m. PST on Thursday, and close at noon PST on Friday.

Please follow the proceedings of the Commission’s meeting through this blog and through a live-stream Webcast on the Commission website at The Webcast will be archived on the website, and a transcript of the proceedings will be posted following the meeting.

Share this article

1 Comment to Live from San Francisco

  1. March 25, 2012 at 1:38 pm | Permalink

    Very informative. I personally am very concerned on the privacy issue.

Leave a Reply

Read the comment policy before posting your comment.


This is a space for the members and staff of the Presidential Commission for the Study of Bioethical Issues to communicate with the public about the work of the commission and to discuss important issues in bioethics.

Learn more about the Presidential Commission for the Study of Bioethical Issues.


You can receive updates about our blog via email subscription, RSS feed, or follow the Bioethics Commission on Twitter.